Evidence map›Paper›PMID 41120364›Full record

ArticleScientific reports2025

Investigation of Akt1 behavior on gold surface from molecular dynamics insight.

Farzane Abasi Joozdani, Mohammad Reza Amiran, Majid Taghdir

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Farzane Abasi JoozdaniDepartment of Biophysics, Faculty of Biological Science, Tarbiat Modares University, Tehran, 14115_111, Iran.
Mohammad Reza AmiranDepartment of Biophysics, Faculty of Biological Science, Tarbiat Modares University, Tehran, 14115_111, Iran.
Majid TaghdirDepartment of Biophysics, Faculty of Biological Science, Tarbiat Modares University, Tehran, 14115_111, Iran. Taghdir@modares.ac.ir.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the past few years, gold nanoparticles (AuNPs) have shown great roles in biomedical areas. They can interact with proteins and change their structure and function. The serine/threonine kinase AKT plays a key role in cellular processes. Therefore, the AKT protein is known as a drug target for cancer treatment. In this study, we assessed the effect of gold nanoparticles on the AKT1 protein using molecular docking and molecular dynamics simulation. The results show that the AKT1 protein binds to citrate-coated gold surface predominantly through electrostatic and hydrophobic interactions. The RMSF calculations show that the AKT1 protein in the presence of gold nanoparticles exhibits less dynamic than the free state. The presence of gold nanoparticles causes the protein to have less compactness. The linker domain in the inactive conformation, and the regulatory domain and the glycine-rich loop in the active conformation of the AKT1 protein have higher dynamics than other regions. Furthermore, free energy landscape calculations show that AKT1 protein has a more conformational entropy in complex states in two active and inactive conformations. The results show that gold nanoparticles can affect the AKT1 protein and as a result, inhibit the phosphorylation flow in the protein signaling pathway in cancer cells.

Indexed as

GoldMetal NanoparticlesMolecular Dynamics SimulationProto-Oncogene Proteins c-aktHumansHydrophobic and Hydrophilic InteractionsMolecular Docking SimulationProtein BindingProtein ConformationStatic ElectricitySurface PropertiesAKT1 protein, humanGoldProto-Oncogene Proteins c-aktAKT proteinElectrostatic interactionGold nanoparticlesMolecular dynamics

Identifiers

PMID41120364
PMCPMC12540876

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.